How Hospitals and PBMs Profit—and Patients Lose—From 340B Contract Pharmacies
The stunning growth of specialty pharmacies in the 340B Drug Pricing Program has accelerated a troubling trend: Patients covered by commercial insurance and Medicare Part D are footing the bill for 340B savings.
